Erickson Michael G's Form 4 filing
IDEXX Laboratories IncIDXX · filed Feb 19, 2026
- Accession no.
- 0000874716-26-000033
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 13 non-derivative transactions and 7 derivative transactions. Open-market sales total $3.37M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Erickson Michael GCIK 0002005385 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +1,191 | $141.60 | +$168,645.6 | 13,884.35 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +4,180 | $178.26 | +$745,126.8 | 18,064.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −456 | $623.76F1 | −$284,434.56 | 17,608.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −204 | $625.24F2 | −$127,548.96 | 17,404.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −1,288 | $626.26F3 | −$806,622.88 | 16,116.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2,694 | $628.22F4 | −$1,692,424.68 | 13,422.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −689 | $629.09F5 | −$433,443.01 | 12,733.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −40 | $629.86 | −$25,194.4 | 12,693.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +719 | $141.60 | +$101,810.4 | 13,412.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +817 | $178.26 | +$145,638.42 | 14,229.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +483 | $206.94 | +$99,952.02 | 14,712.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +183 | $544.08 | +$99,566.64 | 14,895.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +197 | $505.53 | +$99,589.41 | 15,092.35 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −1,191 | $0.00 | $0 | 0 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −4,180 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −719 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −817 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −483 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −183 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −197 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of the shares sold ranging from a low of $623.28 to a high of $624.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average price of the shares sold ranging from a low of $624.89 to a high of $625.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold ranging from a low of $626.045 to a high of $628.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold ranging from a low of $627.74 to a high of $628.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of the shares sold ranging from a low of $628.755 to a high of $629.615 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.